201 related articles for article (PubMed ID: 19933789)
1. Prevention of severe cutaneous adverse drug reactions: the emerging value of pharmacogenetic screening.
Fernando SL; Broadfoot AJ
CMAJ; 2010 Mar; 182(5):476-80. PubMed ID: 19933789
[No Abstract] [Full Text] [Related]
2. HLA-B allele associations with certain drugs are not confirmed in Japanese patients with severe cutaneous drug reactions.
Kano Y; Hirahara K; Asano Y; Shiohara T
Acta Derm Venereol; 2008; 88(6):616-8. PubMed ID: 19002350
[No Abstract] [Full Text] [Related]
3. Genetic susceptibilities and prediction modeling of carbamazepine and allopurinol-induced severe cutaneous adverse reactions in Vietnamese.
van Nguyen D; Chu HC; Vidal C; Fulton RB; Nguyen NN; Quynh Do NT; Tran TL; Nguyen TN; Thu Nguyen HT; Chu HH; Thanh Thuc HT; Minh Le HT; van Nunen S; Anderson J; Fernando SL
Pharmacogenomics; 2021 Jan; 22(1):1-12. PubMed ID: 33356553
[No Abstract] [Full Text] [Related]
4. Stratification of the risk of serious allergic cutaneous reactions with therapeutic management of trigeminal neuralgia.
Shakib K; Sinanan M
Br J Oral Maxillofac Surg; 2011 Apr; 49(3):235-6. PubMed ID: 20430493
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of cutaneous adverse drug reactions.
Aihara M
J Dermatol; 2011 Mar; 38(3):246-54. PubMed ID: 21342226
[TBL] [Abstract][Full Text] [Related]
6. Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing.
Hershfield MS; Callaghan JT; Tassaneeyakul W; Mushiroda T; Thorn CF; Klein TE; Lee MT
Clin Pharmacol Ther; 2013 Feb; 93(2):153-8. PubMed ID: 23232549
[TBL] [Abstract][Full Text] [Related]
7. HLA-B*58:01 is strongly associated with allopurinol-induced severe cutaneous adverse reactions in Han Chinese patients: a multicentre retrospective case-control clinical study.
Cheng L; Xiong Y; Qin CZ; Zhang W; Chen XP; Li J; Zhou HH
Br J Dermatol; 2015 Aug; 173(2):555-8. PubMed ID: 26104483
[No Abstract] [Full Text] [Related]
8. HLA Allele Frequencies in 5802 Koreans: Varied Allele Types Associated with SJS/TEN According to Culprit Drugs.
Park HJ; Kim YJ; Kim DH; Kim J; Park KH; Park JW; Lee JH
Yonsei Med J; 2016 Jan; 57(1):118-26. PubMed ID: 26632391
[TBL] [Abstract][Full Text] [Related]
9. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis.
Kaniwa N; Saito Y; Aihara M; Matsunaga K; Tohkin M; Kurose K; Sawada J; Furuya H; Takahashi Y; Muramatsu M; Kinoshita S; Abe M; Ikeda H; Kashiwagi M; Song Y; Ueta M; Sotozono C; Ikezawa Z; Hasegawa R;
Pharmacogenomics; 2008 Nov; 9(11):1617-22. PubMed ID: 19018717
[TBL] [Abstract][Full Text] [Related]
10. HLA-B*5801: utility and cost-effectiveness in the Asia-Pacific Region.
Yeo SI
Int J Rheum Dis; 2013 Jun; 16(3):254-7. PubMed ID: 23981744
[TBL] [Abstract][Full Text] [Related]
11. A marker for Stevens-Johnson syndrome ...: ethnicity matters.
Lonjou C; Thomas L; Borot N; Ledger N; de Toma C; LeLouet H; Graf E; Schumacher M; Hovnanian A; Mockenhaupt M; Roujeau JC;
Pharmacogenomics J; 2006; 6(4):265-8. PubMed ID: 16415921
[TBL] [Abstract][Full Text] [Related]
12. HLA-B*5801 should be used to screen for risk of Stevens-Johnson syndrome in family members of Han Chinese patients commencing allopurinol therapy.
Lee MH; Stocker SL; Williams KM; Day RO
J Rheumatol; 2013 Jan; 40(1):96-7. PubMed ID: 23280169
[No Abstract] [Full Text] [Related]
13. Human leukocyte antigen-B*58:01 allele in a familial case of Stevens-Johnson syndrome induced by allopurinol.
Caldarola G; Sollena P; Peris K; De Simone C
J Dermatol; 2015 Jul; 42(7):753-4. PubMed ID: 25899558
[No Abstract] [Full Text] [Related]
14. HLA alleles and drug hypersensitivity reactions.
Profaizer T; Eckels D
Int J Immunogenet; 2012 Apr; 39(2):99-105. PubMed ID: 22136512
[TBL] [Abstract][Full Text] [Related]
15.
Ponzo MG; Miliszewski M; Kirchhof MG; Keown PA; Dutz JP
J Cutan Med Surg; 2019; 23(6):595-601. PubMed ID: 31378082
[TBL] [Abstract][Full Text] [Related]
16. HLA-B*1502 screening in carbamazepine and lamotrigine candidates of Asian background.
Hassan I
Aust N Z J Psychiatry; 2012 Nov; 46(11):1106-7. PubMed ID: 22833576
[No Abstract] [Full Text] [Related]
17. HLA-B*58:01 strongly associates with allopurinol-induced adverse drug reactions in a Japanese sample population.
Niihara H; Kaneko S; Ito T; Sugamori T; Takahashi N; Kohno K; Morita E
J Dermatol Sci; 2013 Aug; 71(2):150-2. PubMed ID: 23669020
[No Abstract] [Full Text] [Related]
18. [HLA-B58.01 and allopurinol hypersensitivity renal vasculitis in a Chinese patient].
Mariette F; Scarfoglière V; Giot M; Basire A; Rouby F; Daniel L; Jourde-Chiche N
Rev Med Interne; 2022 Jul; 43(7):436-439. PubMed ID: 35606203
[TBL] [Abstract][Full Text] [Related]
19. Drug-Induced Skin Adverse Reactions: The Role of Pharmacogenomics in Their Prevention.
Gerogianni K; Tsezou A; Dimas K
Mol Diagn Ther; 2018 Jun; 22(3):297-314. PubMed ID: 29564734
[TBL] [Abstract][Full Text] [Related]
20. Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population.
Tassaneeyakul W; Tiamkao S; Jantararoungtong T; Chen P; Lin SY; Chen WH; Konyoung P; Khunarkornsiri U; Auvichayapat N; Pavakul K; Kulkantrakorn K; Choonhakarn C; Phonhiamhan S; Piyatrakul N; Aungaree T; Pongpakdee S; Yodnopaglaw P
Epilepsia; 2010 May; 51(5):926-30. PubMed ID: 20345939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
